BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3132642)

  • 1. Case-control study to determine the cause of sclerosing peritoneal disease.
    Oulès R; Challah S; Brunner FP
    Nephrol Dial Transplant; 1988; 3(1):66-9. PubMed ID: 3132642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerosing peritonitis.
    Bowers VD; Ackermann JR; Richardson W; Carey LC
    Clin Transplant; 1994 Aug; 8(4):369-72. PubMed ID: 7949541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of peritoneal fibrosing syndromes in peritoneal dialysis.
    Mactier RA
    Adv Perit Dial; 2000; 16():223-8. PubMed ID: 11045299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encapsulating peritoneal sclerosis in patients on peritoneal dialysis.
    Hendriks MP; de Sévaux RG; Hilbrands LB
    Neth J Med; 2008; 66(7):269-74. PubMed ID: 18663253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerosing encapsulating peritonitis in a child secondary to peritoneal dialysis.
    Tan FL; Loh D; Prabhakaran K
    J Pediatr Surg; 2005 May; 40(5):e21-3. PubMed ID: 15937801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.
    Hirahara I; Inoue M; Okuda K; Ando Y; Muto S; Kusano E
    Nephrol Dial Transplant; 2007 Feb; 22(2):560-7. PubMed ID: 17035369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model.
    Bozkurt D; Taskin H; Sezak M; Biçak S; Sen S; Ok E; Duman S
    Adv Perit Dial; 2008; 24():32-8. PubMed ID: 18985998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Encapsulating peritoneal sclerosis--a serious complication of peritoneal dialysis with not characteristic symptoms].
    Kowalewska J; Lichodziejewska-Niemierko M; Liberek T; Mechlińska-Baczkowska J; Nałecz A; Jaśkiewicz K; Rutkowski B
    Wiad Lek; 2006; 59(5-6):419-21. PubMed ID: 17017495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients.
    Gandhi VC; Humayun HM; Ing TS; Daugirdas JT; Jablokow VR; Iwatsuki S; Geis WP; Hano JE
    Arch Intern Med; 1980 Sep; 140(9):1201-3. PubMed ID: 7406618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerosing peritonitis with mural bowel fibrosis in a patient on long-term CAPD.
    Hauglustaine D; van Meerbeek J; Monballyu J; Goddeeris P; Lauwerijns J; Michielsen P
    Clin Nephrol; 1984 Sep; 22(3):158-62. PubMed ID: 6488597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulating peritoneal sclerosis in patients on peritoneal dialysis in Slovenia.
    Lindic J; Rupnik AT; Tomazic J; Skoberne A; Gucek A; Ferluga D; Pintar T; Ales A; Kovac D; Kveder R; Pajek J; Savicki-Ponikvar B; Bren A
    Ther Apher Dial; 2009 Aug; 13(4):282-7. PubMed ID: 19695060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encapsulating peritoneal sclerosis-like findings in a hemodialysis patient without a history of peritoneal dialysis.
    Kawanishi H; Watanabe H; Moriishi M; Tsuchiya S
    Adv Perit Dial; 2003; 19():176-9. PubMed ID: 14763057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Encapsulating peritoneal sclerosis].
    Fantová L; Safárová R; Vanková S
    Vnitr Lek; 2007 Feb; 53(2):164-8. PubMed ID: 17419179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How to diagnose and treat peritoneal infections in patients with terminal chronic renal insufficiency treated by peritoneal dialysis].
    Michel C; al Khayat R; Viron B; Siohan P; Mignon F
    Nephrologie; 1995; 16(1):55-69. PubMed ID: 7700422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulating peritoneal sclerosis in paediatric peritoneal dialysis patients.
    Ekim M; Fitöz S; Yagmurlu A; Ensari A; Yüksel S; Acar B; Ozçakar ZB; Kendirli T; Bingöler B; Yalçinkaya F
    Nephrology (Carlton); 2005 Aug; 10(4):341-3. PubMed ID: 16109078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model.
    Duman S; Bozkurt D; Sipahi S; Sezak M; Ozkan S; Ertilav M; Sen S; Ok E
    Adv Perit Dial; 2008; 24():104-10. PubMed ID: 18986012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal permeability in patients with encapsulating peritoneal sclerosis.
    Fang CC; Tsai TJ
    Am J Kidney Dis; 2006 Nov; 48(5):875; author reply 875-6. PubMed ID: 17060010
    [No Abstract]   [Full Text] [Related]  

  • 18. Peritoneal sclerosis.
    Di Paolo N; Garosi G
    J Nephrol; 1999; 12(6):347-61. PubMed ID: 10626824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal mast cells in peritoneal dialysis patients, particularly in encapsulating peritoneal sclerosis patients.
    Alscher DM; Braun N; Biegger D; Fritz P
    Am J Kidney Dis; 2007 Mar; 49(3):452-61. PubMed ID: 17336707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.